On a mission: effective treatments for rare cancer patients

On a mission: effective treatments for rare cancer patients. One year of progress.

On the 9th of October, Stichting Yamicc celebrated its first official anniversary! A milestone, and a great moment to reflect.

We are laying the foundation to make clinical trials for rare cancers cheaper, faster, and more effective. Here’s a glimpse of what has happened since:

✔️ ANBI status
✔️ Promising partnerships
✔️ Establishment of a strong governance structure
✔️ Yamicc Platform development
✔️ Yamicc Live launching event in Rotterdam
✔️ First donation
✔️ Key milestones in the ReDiReCCT-GB trial
✔️ Last, but definitely not least: we are growing our team of passionate experts, all highly driven to make a difference.

We’re proud of what’s been built, and deeply grateful to all who contributed. Team, partners, researchers, clinicians, data experts, donors and volunteers: thank you.

And year two?
We continue to build, scale and aim for the highest.
Because every rare cancer patient deserves an effective treatment.

English